Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
May 31, 2020
Aug. 31, 2019
Current Assets    
Cash and cash equivalents $ 1,279,256 $ 4,423,965
Prepaid expenses and other current assets 74,655 18,623
Deferred offering costs 98,715  
Total Current Assets 1,452,626 4,442,588
Equipment, net of accumulated depreciation of $1,144 and $792, respectively 1,484 721
Intangible asset 2,039,417 2,039,417
TOTAL ASSETS 3,493,527 6,482,726
Current Liabilities    
Accounts payable and accrued liabilities 255,632 348,863
Due to related party 12,825 3,732
Derivative liability   29,501
Stock payable   639,417
Total Current Liabilities 268,457 1,021,513
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 6,250,000 shares authorized, 0 and 0 shares issued and outstanding, respectively
Common Stock, par value $0.001, 18,750,000 shares authorized, 3,733,604 and 3,353,616 shares issued and outstanding, respectively 3,734 3,354
Additional paid-in capital 11,609,266 10,278,421
Accumulated deficit (8,438,434) (4,810,756)
Accumulated other comprehensive income (loss) 50,504 (9,806)
Total Stockholders' Equity 3,225,070 5,461,213
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,493,527 $ 6,482,726